Clinical Trial Update: Intervention to End Recurrent Unscheduled Bleeding Trial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial completed for an intervention aimed at ending recurrent unscheduled bleeding in contraception-related settings; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bleeding
• Contraception

Snippet

Sponsor: Washington University School of Medicine | Conditions: Contraception, Bleeding | Phase 3 | Status: COMPLETED | Results posted: 2018-08-31